SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Gensel Biotech GSB(ASE) -- Ignore unavailable to you. Want to Upgrade?


To: Tim Davies who wrote (1)5/23/1999 11:45:00 AM
From: Murray Nightingale  Read Replies (1) | Respond to of 8
 
The company has received a lot of calls since they announced their joint venture with Monsanto-- about 6 a day since the announcment. yorkton crossed 100,000 shares of the company on March 29, 1999 at 32 cents so someone tere has a passing interest in the company. Yorkton probably was aware of the joint ventures that were to be announced in April and May. GSB have very strong financial and technical support behind them with the three joint ventures just anounced. i spoke with the VP, Mr. Henderson and he told me that before they announced these deals they thought commercialization was three years away but now they expect that period to be shorter.

I do think that this stock is one worth investing in. I rarely buy shares of small caps that are not making money but I am prepared to make an exception in this case. Dont be turned off by the thin trading. That can change very quickly. I owned GLE on the tse(formerly ase) for two years at .80-1.00. it hardly moved or traded and then the thing took off. The float is O.K. Buy now while the shares are still cheap.